Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Quality of Life × Anastrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 100 Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Intraductal, Noninfiltrating 4 Arthralgia 4 Advanced Breast Cancer 4 Osteoporosis 2 Multiple Endocrine Neoplasia Type 1 2 Breast Neoplasms, Male 2 Breast Carcinoma In Situ 2 Breast Cancer Metastatic 2 Triple Negative Breast Neoplasms 1 Sexual Dysfunction, Physiological 1 Seizures 1 Recurrence 1 Quality of Life 1 Pain 1 Ovarian Neoplasms 1 Obesity 1 Lethal Congenital Contracture Syndrome 2 1 Joint Diseases 1 Invasive Breast Cancer 1 Hypogonadism 1 Granulosa Cell Ovarian Cancer 1 Fractures, Bone 1 Erectile Dysfunction 1 Epilepsy 1 Bone Diseases, Metabolic 1 Bone Density 1 Advanced Metastatic Breast Cancer 1

Interventions

apatinib 1 Yoga 1 Tamoxifen 1 Referral and Consultation 1 Fentanyl 1 Educational Status 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00784680 2009-05-01

ATAC - Quality of Life Sub-Protocol

AstraZeneca

Phase 3 Completed

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡